Medical Australia
Medical Australia (ASX: MLA) is engaged in the development, manufacture and distribution of a range of medical devices. The company is focused on five clinical therapy areas within the broader medical devices market – intravenous (IV) systems, safety (injection, collection, destruction), blood banking, surgical products and anaesthesia products.
In-Depth Medical Australia Articles
Archive-
30/04/2012
Medical Australia completes milestone first animal stem cell treatments in U.K.
The TUTAVet animal stem cell therapy has substantial commercial upside for Medical Australia. Following the completion of the first two procedures in the U.K. the company has generated strong interest from veterinary surgeons keen to trial the technology.
-
03/04/2012
Medical Australia secures first mover advantage in Europe with animal stem cell therapy
Mark Donnison, managing director of Medical Australia, told Proactive Investors today the roll out of a new unique regenerative animal stem cell therapy offering in Europe presents the company with three potential revenue streams.
-
22/11/2011
Medical Australia boosts FY2012 revenue by A$1.5m with new supply agreements
New supply contracts indicate the strong organic revenue growth Medical Australia is experiencing across the business and with further prospects the company is on a solid growth footing for FY2012 and beyond.
-
30/09/2011
Medical Australia launches ADRs, takes step into North American market
Medical Australia is making moves on the North American market, with quotation on the Over-The-Counter market in the United States to give the company better access to U.S. investors.
-
23/08/2011
Medical Australia to receive immediate revenue from Smith & Nephew distribution agreement
The latest milestone for Medical Australia is the development of a presence in the North American market, after signing a distribution agreement with Smith & Nephew. The result is immediate revenue generation.
Related Media
Archive-
24/03/2010
Medical Australia One2One Investor Presentation 24 March 2010 (PDF)
Gary Lewis of Medical Australia updates investors at the Proactive Investors One2One Forum: "The Ultimate Healthcare & Biotechnology Event in 2010" on 24 March 2010.
Presentations & Company Media
No documents available.
Related Research & Media
No documents available.
Company Statement:
BMDi TUTA Healthcare is an Australian medical technology company engaged in the manufacture and marketing of a broad range of medical devices used by healthcare professionals globally. Their core strategy is to provide products that improve clinical and community safety by delivering a range of safety engineered medical devices
Current Operations:
BMDiTUTA Healthcare, a leader in IV Medication Delivery Systems, Surgical Irrigation, Suction Oxygen Therapy and Safety Sharps Collection and Reuse Prevention. Our strong heritage derived from the merging of Tuta, Clements and BMDi spans more than 100 years supporting the Australian and Global healthcare needs in our specialist areas. In addition to our own product range we are proud to have long term associations with Hakko, Sebra and iFLow providing complementary products and solutions covering Anaesthesia spinal needles, Bloodbanking, BioPharm and Laboratory equipment and Ambulatory Infusion devices. We are proud to present to you our range of leading, quality and innovative product solutions.
Management
Gary Lewis
BCom MBT (UNSW)
Managing Director
Michael Neville
MBA MAICD
Chief Operating Officer
Mark McEnallay
FCPA GAICD
Chief Financial Officer
Michael Jones
General Manager, Corporate Innovation
David Thomson
General Manager, Quality Assurance Regulatory Affairs
Major Shareholders
At 15 September, 2008, the distribution of fully paid ordinary shares was:
|
Range |
Total Holder |
Fully Paid Ordinary |
% Issued Capital |
||||
|
1 - 1000 |
38 |
376 |
0.00 |
||||
|
1001-5000 |
9 |
31,542 |
0.02 |
||||
|
5001-10,000 |
68 |
643,494 |
0.35 |
||||
|
10,001-100,000 |
175 |
7,428,375 |
4.09 |
||||
|
100,001 and over |
137 |
173,660,579 |
95.54 |
||||
|
181,764,366 |
100.0 |
||||||
Contact Information
Level 17, 275 Alfred Street
North Sydney, NSW, Australia, 2060
Phone: +61-2 9466 5300
Fax: +61-2 9922 7165
Customer Service: 1300 361 162
Website: www.bmdituta.com
Corporate Information
Registered Office
Level 11, 37 Bligh Street
SYDNEY NSW 2000 Australia
Phone: +61 29232 5444
Fax: +61 2 9232 6826
Email: info@bmdituta.com
Website: www.bmdituta.com
Principal Office
Level 17, 275 Alfred Street
NORTH SYDNEY NSW 2060 Australia
Phone: +61-2 9466 5300
Fax: +61-2 9922 7165
Auditors
Gould Ralph Assurance, Chartered Accountants
Level 42, 259 George St
SYDNEY NSW 2000
Share Registrar
Gould Ralph Pty Limited
Level 42, 259 George St
SYDNEY NSW 2000
Phone: +61 2 9032 3000
Fax: +61 2 9032 3088
